Company: GRCE
Filing Date: 2025-06-23
Form Type: 8-K
Source: 0001140361-25-023261
Chunk: 0

Company: Grace Therapeutics, Inc.
Filing Date: 2025-06-23
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02      Results of Operations and Financial Condition.  

The following information is furnished pursuant to Item 2.02 “ Results of Operations and Financial Condition.”

On June 23, 2025, Grace Therapeutics, Inc. (formerly Acasti Pharma Inc.) issued a press release announcing its financial results for the fiscal year
ended March 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

The information in this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, or the
Exchange Act, regardless of any general incorporation language in such filing, except as expressly set forth by specific reference in such a filing or document.

  Item 9.01      Exhibits.